
UAE approves tobacco-free nicotine pouches to help smokers quit cigarettes
Tobacco-free nicotine pouches will be legally available for purchase in the UAE starting July 29, when a new law regulating the product comes into effect.
A UAE Cabinet resolution outlines the technical standards for this smoking alternative, designed to help people quit cigarettes.
Dr Sanam Mallick, Consultant in Family Medicine at Burjeel Hospital Abu Dhabi, described the pouches as small, smokeless products that contain nicotine but no tobacco.
'People place them between their gum and lips to absorb nicotine without smoking or chewing tobacco. They're popular as a discreet alternative to cigarettes or chewing tobacco. Nicotine pouches contain nicotine, the same chemical that we find in tobacco,' he told Khaleej Times.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
Nicotine is an addictive substance. These pouches release dopamine, the 'feel-good hormone', which helps reduce cravings and withdrawal symptoms, thereby aiding smoking cessation.
'Nicotine pouches can be a valuable tool for some people trying to quit smoking, but whether they're a good option compared to other smoking cessation methods depends on a few factors,' Dr Mallick explained.
One benefit is the absence of smoke inhalation, which significantly lowers the risk of lung damage compared to traditional smoking. However, like all nicotine products, the pouches can be addictive.
'They still contain nicotine, so they don't remove the addiction, just the smoking behaviour. (Additionally), because they're relatively new, the long-term health impacts are still being studied,' he added.
On their effectiveness, Dr Mallick noted that while some smokers report success in using pouches to gradually reduce or replace cigarettes, others struggle with the continued oral habit. 'Others may find the oral fixation or habit harder to break, since pouches still involve placing something in the mouth (similar to chewing tobacco).'
Traditional nicotine replacement therapies (NRTs) such as patches, gum, and lozenges are known to increase quit rates by 50 to 70 per cent. 'Nicotine pouches might offer similar benefits, but without long-term studies, their effectiveness compared to these therapies is less certain.'
Patches vs pouches
Shiraz Khan, Chief Operating Officer at Aster Retail GCC, explained that nicotine from pouches is absorbed through the lining of the mouth.
'In contrast, nicotine patches are transdermal products applied to the skin. They slowly release nicotine into the bloodstream over a period of time, helping to reduce withdrawal symptoms and cravings,' he said. 'The key difference lies in the method of delivery. Pouches work via oral mucosal absorption, while patches deliver nicotine through the skin.'
NRTs such as patches, gum, and lozenges are already available in UAE pharmacies. 'These products are typically available over the counter (OTC) and do not require a prescription. However, some higher-dose patches or combination therapies might be recommended under a healthcare provider's supervision,' Khan said.
He added that NRTs are a popular choice among smokers looking to quit. 'Products like nicotine gums and lozenges have seen rapid growth due to their discreet use, lack of smoke, and perceived lower harm compared to traditional tobacco products.'
All nicotine products in the UAE must carry health warnings and age restriction labels, with sales prohibited to those under 18.
'Packaging and labelling must comply with UAE-specific guidelines, including Arabic labelling. Only licensed retailers or pharmacies may sell these products,' Khan added.
Tobacco's toll
Globally, tobacco remains the leading preventable cause of disease and premature death, according to a guide released last year by the UAE Ministry of Health and Prevention (Mohap). The global tobacco epidemic claims nearly eight million lives annually, making it one of the most serious public health threats.
The National Health Survey of 2018 found that nearly 16 per cent of men and 2.5 per cent of women in the UAE are smokers, the guide said.
To support tobacco cessation efforts, authorities said that counselling and psychological support will be offered to individuals attempting to quit all forms of tobacco, including e-cigarettes.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
an hour ago
- Zawya
DoH and Boehringer Ingelheim Ink strategic partnership to advance life science innovation across the Emirate
Abu Dhabi, United Arab Emirates: The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, one of the world's leading research-driven pharmaceutical companies. This strategic partnership aims to advance scientific research and innovation, foster groundbreaking research and development and cultivate an environment of scientific excellence, further cementing the Emirate as the MENA region's premier hub for healthcare, life sciences and innovation. In the presence of H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi and Ousama Alhaj, General Manager and Head of Human Pharma, Near East and UAE at BI, the agreement was signed during BIO International Convention in Boston at the Abu Dhabi Pavilion by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Ghaleb Al Ahdab, Head of Public and Government Affairs, Near East and UAE at BI. Through this strategic partnership, the two parties seek to strengthen the Emirate's research ecosystem by facilitating access to and harnessing the capabilities of Boehringer Ingelheim'sOpnME platform. Researchers, scientists and innovators across Abu Dhabi will be able to leverage the platform's cutting-edge data and resources to address critical biological challenges and accelerate scientific discovery. Through four flagship programmes, Molecule to Order (M2O), Molecule for Collaboration (M4C), opn2EXPERTS (o2e) and opnTALENTS (o25), the platform empowers the research community with access to advanced compounds, collaborative opportunities, expert networks and support for emerging talent. OpnME connects visionary researchers to champion transformative, research-driven medical innovation for generations to come. In line with Abu Dhabi's vision to shape the future of healthcare, this partnership between DoH and BI enhances knowledge exchange and invests in local talent. It offers scientists a purpose-driven, globally connected environment to lead impactful research, further reinforcing the Emirate's commitment to transforming the regional healthcare ecosystem through science and technology. Dr. Asma Ibrahim Al Mannaei, the Executive Director of the Health Life Sciences Sector at DoH, said: 'Our partnership with Boehringer Ingelheim reflects our commitment to pioneering innovation and scientific research as parts of our efforts to advance health outcomes and improve the quality of life for communities around the world. We're empowering Abu Dhabi researchers with the opnMe platform, an open portal offering top-tier pharmaceutical compounds, fostering collaboration and safeguarding researchers' rights to their findings. This is about transforming our emirate into a global life sciences hub, speeding up breakthroughs, and building a healthier, resilient future for all.' Ousama Alhaj, General Manager and Head of Human Pharma for Near East and UAE at Boehringer Ingelheim, said: 'At Boehringer Ingelheim, we are proud to partner with the Department of Health – Abu Dhabi (DoH) to empower the scientific community through our OpnMe platform. This collaboration reflects our shared commitment to advancing research and innovation in the region, fostering a culture of discovery, and ultimately improving patient outcomes. By providing access to our scientific resources, including advanced compounds, collaborative research opportunities, and expert networks, we aim to inspire new ideas and support the next generation of researchers in Abu Dhabi.' Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 14 to 21, delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI). About the Department of Health – Abu Dhabi (DoH): The Department of Health – Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual.


Zawya
3 hours ago
- Zawya
MOHAP strengthens cooperation with partners to implement a National Roadmap for Addressing Health Risks
Workshop to launch the 'National Policy for Combating Health Risks' and to establish the policy's executive framework. Coordination at all levels through building effective national partnerships and networks and international cooperation. His Excellency Al Olama: The policy's focus on good governance and institutional empowerment constitutes a fundamental pillar for establishing comprehensive national health security. UAE, Dubai: The Ministry of Health and Prevention held a workshop titled "Launching the National Policy for Combating Health Risks in the UAE." The workshop was attended by broad participation from relevant stakeholders, including health authorities and other entities. The aim was to introduce its pillars following its approval by the UAE Cabinet. The workshop also discussed the framework of the executive plan emanating from the policy and enhanced coordination among all relevant partners to ensure integrated efforts related to combating health risks and to ensure the achievement of the policy's vision and objectives. This will contribute to adopting a multi-sectoral approach to health risk preparedness and response, meeting the aspirations of the UAE Centennial 2071 vision. Wide Participation The workshop was opened by His Excellency Dr. Salem Al Darmaki, Advisor to the Minister of Health and Prevention, with the participation of representatives from the National Emergency, Crisis and Disaster Management Authority, the Presidential Court, the Ministry of Interior, the Ministry of Climate Change and Environment, the Ministry of Economy, the Ministry of Energy and Infrastructure, the Federal Authority for Identity and Citizenship, Customs and Ports Security, the General Civil Aviation Authority, the Federal Authority for Nuclear Regulation, the Department of Health - Abu Dhabi, the Emirates Health Services Corporation, the Emirates Drug Establishment, the Dubai Health Authority, the Sharjah Health Authority, Dubai Health, the United Arab Emirates University, and the Emirates Medical Association. Risk Response System The workshop focused on governance frameworks for combating health risks, including building and supporting social, financial, and administrative commitment; coordination at all levels through building effective national partnerships and networks and international cooperation; developing supportive policies and legislation; integrating health into all policies; and mechanisms for managing health risks at all stages, including: Prevention, preparedness, response, and recovery are achieved through monitoring the implementation of the National Framework for Health Risk Management, identifying, analyzing, assessing, and providing early warning of risks, as well as ensuring response and control of the health situation in cases of exposure to health risks and emergencies. Future Planning The workshop addressed strengthening sustainable basic health infrastructure and logistics, maintaining essential and vital health services during health emergencies, ensuring the availability of a sufficiently qualified health workforce, developing interventions for effective response to risk communication, addressing rumors, and providing and analyzing risk data and statistics for evidence-based decision-making. It also focused on strengthening research capacity, establishing systems, and managing innovation in the field of various health risks. It also identified the most important expected improvements in the health sector and beyond it, and developing a future planning process for health risk management. A Proactive Vision His Excellency Dr. Mohammed Salim Al Olama, Undersecretary of the Ministry of Health and Prevention, emphasized that the National Policy for Combating Health Risks in the UAE represents a strengthening of the national response system to health emergencies. This embodies a proactive vision that aligns with the aspirations of wise leadership and the UAE government's ambitions to continuously develop a health sector capable of containing emerging challenges and responding quickly to health crises and emergencies. His Excellency added: "The Ministry operates within a coordinated framework with all government, private, and academic entities, both local and international, within a framework that enhances the integration of roles and establishes a legislative and executive environment capable of achieving sustainable results. Furthermore, the policy's focus on good governance, institutional empowerment, and improving infrastructure efficiency constitutes a fundamental pillar for establishing comprehensive national health security by consolidating the role of community participation as a strategic tool for early detection, disease prevention, and achieving comprehensive preparedness that ensures the continuity of vital services under various circumstances, thus achieving the Ministry's strategy 2023-2026. Dr. Lubna Al Shaali, Director of the Health Policy and Legislation Department at the Ministry of Health and Prevention, indicated that implementing the National Policy for Combating Health Risks will contribute to providing proactive guidance for developing the national capabilities needed to respond to various events and risks and combat their health impacts, in accordance with the latest global and national health practices and guidelines. This will also promote more resilient health systems capable of adapting to future crises through a national framework that consolidates integration among agencies and unifies efforts. She noted that this policy represents a strategic step toward building a robust health system, centered on health in all policies, and aligned with the Ministry's strategy to achieve comprehensive and sustainable health security. Dr. Fatima Al Attar, Director of the International Health Regulations Office at the Ministry of Health and Prevention, indicated that accurate periodic assessment of health risks by strengthening monitoring and early detection systems, classifying these risks, and identifying their sources will enhance preparedness, improve response indicators, reduce mortality and morbidity rates associated with health emergencies and disasters, and enhance the continuity of health coverage in the country.


Al Etihad
4 hours ago
- Al Etihad
Department of Health - Abu Dhabi, Boehringer Ingelheim ink strategic partnership
17 June 2025 13:56 ABU DHABI (WAM) The Department of Health - Abu Dhabi (DoH) signed a Memorandum of Understanding with Boehringer Ingelheim, one of the world's leading research-driven pharmaceutical strategic partnership aims to advance scientific research and innovation, foster groundbreaking research and development, and cultivate an environment of scientific excellence, further cementing the emirate as the MENA region's premier hub for healthcare, life sciences, and the presence of Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi and Ousama Alhaj, General Manager and Head of Human Pharma, Near East and UAE at BI, the agreement was signed during BIO International Convention in Boston at the Abu Dhabi Pavilion by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Ghaleb Al Ahdab, Head of Public and Government Affairs, Near East and UAE at this strategic partnership, the two parties seek to strengthen the Emirate's research ecosystem by facilitating access to and harnessing the capabilities of Boehringer Ingelheim's OpnME scientists, and innovators across Abu Dhabi will be able to leverage the platform's cutting-edge data and resources to address critical biological challenges and accelerate scientific four flagship programmes, Molecule to Order (M2O), Molecule for Collaboration (M4C), opn2EXPERTS (o2e) and opnTALENTS (o25), the platform empowers the research community with access to advanced compounds, collaborative opportunities, expert networks, and support for emerging connects visionary researchers to champion transformative, research-driven medical innovation for generations to Mannaei said, 'Our partnership with Boehringer Ingelheim reflects our commitment to pioneering innovation and scientific research as part of our efforts to advance health outcomes and improve the quality of life for communities around the empowering Abu Dhabi researchers with the opnMe platform, an open portal offering top-tier pharmaceutical compounds, fostering collaboration and safeguarding researchers' rights to their findings. This is about transforming our emirate into a global life sciences hub, speeding up breakthroughs, and building a healthier, resilient future for all.' Alhaj said, 'At Boehringer Ingelheim, we are proud to partner with the Department of Health – Abu Dhabi (DoH) to empower the scientific community through our OpnMe platform. This collaboration supports research, innovation, and the next generation of researchers in the region.'